Health IT

Canadian digital pharmacy TelyRx now trades on OTCQX, a strategic move to access U.S. capital and scale its cash-pay model in a booming market.

Sanofi deepens its partnership with Owkin, licensing its 'K Pro' platform to build autonomous AI agents. A look at the strategy behind this major bet.

In a move signaling a new era for Chinese healthcare, Fangzhou and Tencent are combining specialized AI with massive tech scale. Is this the blueprint for market dominance?

Julie Mueller's move to acquire 100% of Custom Design Benefits isn't just a transaction; it's a strategic bet on independence in a consolidating market.

Struggling biotech Tempest Therapeutics adds finance and medical heavyweights to its board. Is this a strategic reset or a last-ditch effort to survive?

HELP USA's recent gala honored leaders in housing, but the real story is the innovative fusion of finance, policy, and healthcare creating scalable solutions.

A $90M investment in a homeless shelter is more than charity; it's a blueprint. Sun Life's model signals a shift from philanthropy to strategic impact investing.

A new class of doctor is bridging the gap between lab and patient. Meet the physician-scientists tackling deadly diseases with revolutionary new approaches.

A new acquisition seems routine, but it's part of Principle Health's aggressive strategy to build a diagnostic empire for long-term care. Here's why.

A French firm is using a special economic zone to bypass China's tough regulations. Is its scarless vein treatment a medical breakthrough or a brilliant market hack?

NaphCare defends its Alabama prison healthcare contract, touting awards and stability. But can its playbook build lasting value in a deeply troubled system?

Senté renewed its pact with a top scientist. We explore how deep scientific partnerships are becoming the key differentiator in a crowded, hype-filled market.

Swedish innovator Triomed AB unveils a system that triples ultrafiltration in peritoneal dialysis, tackling a critical patient risk and challenging market leaders.

Beyond the headlines of a new cancer therapy, French biotech Oncovita is executing a masterclass in strategy, leveraging a modified measles virus and AI.

New data on 20,000+ exams reveals a shocking weakness in first aid for common injuries, prompting a call to reform California's certification standards.

Trace One's new AI platform promises to end the manual grind of food product development, turning hours of regulatory research into seconds. Here’s how.

The 3rd annual National STEM Festival brings PhD-level student research to D.C., connecting young builders with leaders to solve real-world workforce shortages.

With millions set to lose Medicaid under new federal rules, Azara Healthcare’s acquisition of Advocatia creates a new tech arsenal for at-risk providers.

As Liberty Hill's population skyrockets, the arrival of a freestanding ER ends residents' long drives for urgent care, a milestone for the booming suburb.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.